Join
Login
Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Mike Havrilla
Author's Profile
Author's Articles
Author's Website
Bookmark This Page
Author's Stock Cloud
MXM
NCI
OPMR
ASX
ICAD
QTM
APOL
SCI
PFS
PSA
ABIO
ABT
ACAD
ACCP
ACOR
ACUR
AEZS
AGEN
AGN
ALKS
ALTH
AMAG
AMGN
ANPI
APPA
ARNA
ARYX
AUXL
AVNR
AZN
BDSI
BIIB
BMRN
BMY
BSTC
BSX
BVX
CEGE
CEPH
CERN
CHTP
CLDA
CLDX
CRL
CRXX
CTIC
CVM
CYTR
CYTX
DCTH
DDSS
DNA
DNDN
DSCO
DYAX
ECLP
EXAS
FOLD
GENZ
GILD
GSK
GTXI
HEB
HGSI
HITK
HOLX
IGXT
INCY
INO
INSM
IPXL
ISIS
ISTA
JAV
JAZZ
JNJ
KERX
KG
LLY
LRP
MDCO
MDRX
MEDX
MELA
MNKD
MNT
MNTA
MRGE
MRK
MRX
MYL
NBS
NEPH
NFLD
NGSX
NSPH
NVO
NVS
ONTY
OREX
OSIP
OSIR
OSTE
OSUR
PARD
PBIO
PFE
PGNX
PLX
POZN
PPHM
PRX
PSDV
PTIE
QCOR
RHHBY
RMTI
RPRX
SGP
SHPGY
SLXP
SNTS
SNY
SOMX
SPPI
SVNT
TDLP
TEVA
THOR
THRX
TRIB
TSPT
UTHR
VION
VVUS
WPI
WYE
XNPT
YMI
ACI
Author's Latest Articles
1
2
3
4
5
6
7
8
9
Page size:
select
10
20
50
178
items in
9
pages
Updated Executive Summary For Access Pharma (OTC: ACCP.OB)
Feb 04, 2010 10:59 PM |
ACCP
Keryx / Aeterna Drug Shows Promise In Late-Stage Colon Cancer Patients
Jan 27, 2010 10:32 AM |
AEZS
,
KERX
Mentor Capital Plans Early '10 Launch Of Cancer Vaccine Active Index Fund
Jan 19, 2010 10:25 AM |
DNDN
,
MNT
Healthcare Conference Updates: AUXL, CTIC, CYTX, KERX
Jan 15, 2010 04:40 PM |
AUXL
,
CTIC
,
CYTX
,
KERX
Unilife Medical Poised for NASDAQ: UNIS Trading Debut
Jan 13, 2010 12:30 PM |
SNY
Protox Therapeutics Reports Positive Results For BPH Treatment
Jan 11, 2010 12:42 PM |
Keryx Biopharma (NASDAQ: KERX): Well-Funded Comeback Story With Multiple Catalysts
Jan 09, 2010 06:02 PM |
AEZS
,
AMGN
,
GENZ
,
KERX
Cytori (NASDAQ: CYTX): FDA 510(k) Celution Clearance, Heart Data Pending
Jan 08, 2010 10:23 AM |
APOL
,
CYTX
Access Pharma: ProLindac Well Positioned As Improved, Safer Platinum Drug
Jan 07, 2010 05:33 PM |
PARD
,
SPPI
ProActive HavRx Stock Indexes At Investors YOU
Dec 27, 2009 12:00 PM |
Many Reasons To Launch A Global Generic Drug ETF
Dec 24, 2009 05:49 PM |
MYL
,
NVS
,
PFE
,
TEVA
,
WPI
Mentor Capital / QI, Cancer Vaccine Investing Update Report
Dec 23, 2009 01:37 PM |
ACI
,
AGEN
,
CVM
,
DNA
,
DNDN
,
EEEE
Mentor Capital Plans Early '10 Launch Of Cancer Vaccine Active Index Fund
Dec 21, 2009 11:05 PM |
DNDN
New Era Begins For NeoStem (AMEX: NBS) Following China Acquisition
Dec 16, 2009 12:06 PM |
Access Pharma (OTC: ACCP.OB) Update, CEO Interview
Dec 15, 2009 01:17 PM |
ACCP
Unilife Medical (ASX: UNI.AX) (UNIFF.PK): Recent Sell-Off Unwarranted, Quick Rebound Likely
Dec 14, 2009 12:18 PM |
SNY
Cytori's (NASDAQ: CYTX) Natural Celution for Breast Reconstruction
Dec 13, 2009 03:21 PM |
APOL
,
CYTX
ImmunoCellular (OTC: IMUC.OB) Notches Deal For New Cancer Stem Cell Vaccine Target
Dec 02, 2009 11:09 AM |
GSK
,
MRK
BioMed News Bytes: Merck KGaA, BioMarin, Cytori, Theravance
Nov 30, 2009 06:00 PM |
AFT
,
BMRN
,
CRL
,
CYTX
,
MDCO
,
MRK
Cancer Vaccines: Investing Opportunities Beyond Dendreon (NASDAQ: DNDN)
Nov 28, 2009 12:04 PM |
ACI
,
AGEN
,
CEGE
,
CRL
,
CVM
,
DNA
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.